Stay updated on KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.

Latest updates to the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page
- Check5 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information about KPI-121 0.25% ophthalmic suspension for dry eye disease, while a new revision number has been added.SummaryDifference8%
- Check13 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check56 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check70 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check78 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.